![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|16|27|2998-3006
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.16, Iss.27, 2010-09, pp. : 2998-3006
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bisphosphonates as Treatment of Bone Metastases
Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prevention of bone metastases in prostate cancer
Inpharma, Vol. 1, Iss. 1392, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bisphosphonate Treatment of Lytic Bone Metastases
By Lipton A.
Drugs & Aging, Vol. 14, Iss. 4, 1999-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Toni M. Dando Lynda R. Wiseman
Drugs & Aging, Vol. 21, Iss. 14, 2004-01 ,pp. :